We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Western Blotting Processors Market to Reach USD 329 Million by 2028

By LabMedica International staff writers
Posted on 20 Sep 2018
Print article
Image: The western blotting processors market is expected to grow from USD 200 million to USD 329 million by 2028 (Photo courtesy of Next Advance).
Image: The western blotting processors market is expected to grow from USD 200 million to USD 329 million by 2028 (Photo courtesy of Next Advance).
The western blotting processors market is projected to grow at a CAGR of 5.1% from an estimated USD 200 million in 2018 to just under USD 329 million towards the end of 2028, driven partly by the increasing cases of HIV globally as western blot is a confirmed test that can detect anti-HIV antibodies in blood serum samples.

These are the latest findings of Future Market Insights (Valley Cottage, NY, USA), a market intelligence and consulting firm.

The western blotting processors market is highly competitive with the top companies accounting for a major portion of the global sales. Leading companies are acquiring smaller companies and expanding their production capacities to capture a larger share of the global market. Companies in the western blotting processors market are leveraging the available market opportunities to launch their products in full gear in the global market. Product registration followed by commercialization is accelerating the product launch process and creating healthy competition in the global market for western blotting processors. Additionally, manufacturers of western blotting processors are setting up production facilities in other countries to benefit from access to cheap labor and resource expertise, and realign their distribution and customer-oriented strategies.

However, advanced automated western blotting devices, such as high performance western blotting transfer systems, are more highly priced in comparison to their traditional counterparts, thus restricting their adoption in most developing economies. In regions with high labor costs, cheap traditional western blotting processors are still being used to perform protein tests, resulting in time-consuming and high labor cost-inducing processes. Additionally, the global western blotting processors market has witnessed the launch of a few advanced products in recent years. Further, results obtained from the western blotting process are not completely reliable or consistent and the devices are required to be updated regularly for producing more efficient and reliable results. These factors are expected to pose a challenge to the revenue growth of the global western blotting processors market.

Related Links:
Future Market Insights

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.